ロード中...
New emerging targets in cancer immunotherapy: CD137/4-1BB costimulatory axis
CD137 (4-1BB) is a surface glycoprotein that belongs to the tumour necrosis factor receptor family (TNFRSF9). Its expression is induced on activation on a number of leucocyte types. Interestingly, for cancer immunotherapy, CD137 becomes expressed on primed T and natural killer (NK) cells, which on l...
保存先:
| 出版年: | ESMO Open |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7333812/ https://ncbi.nlm.nih.gov/pubmed/32611557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2020-000733 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|